Search research articles
Contact Us
Filters
Showing results (121-130 of 219) with videos related to
Page
of 22
Sort By:
Crohn'S & Colitis 360
|
November 1, 2019
Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing
Mona Rezapour, Maria Alejandra Quintero, Nidah S Khakoo, et al.
Clinical and Translational Gastroenterology
|
June 26, 2025
Relationship of Intestinal Ultrasound With Clinical, Biochemical, and Endoscopic Disease Severity in Acute Severe Ulcerative Colitis: A Blinded, Prospective Study
Phillip Gu, David Ziring, Puja V Khanna, et al.
The American Journal of Gastroenterology
|
January 19, 2005
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab
Konstantinos A Papadakis, Omid A Shaye, Eric A Vasiliauskas, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 11, 2009
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis
Ryan Ungaro, Masayuki Fukata, David Hsu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 3, 2024
Early Life and Childhood Environmental Exposures, More Than Genetic Predisposition, Influence Age of Diagnosis in a Diverse Cohort of 2952 Patients With IBD
Nidah S Khakoo, Ashley H Beecham, Jiangnan Lyu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2010
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab
William J Sandborn, Maria T Abreu, Geert D'Haens, et al.
Inflammatory Bowel Diseases
|
September 25, 2024
Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease
Fatima S Hussain, Tomas Potlach, Xiaofei Chi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease
Uma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring
Amy Hemperly, Marla C Dubinsky, Andres Yarur, et al.
Gastroenterology
|
February 13, 2026
Quorum sensing molecules are elevated in long-standing ulcerative colitis and are linked to the development of colitis-associated cancer
Gregory O'Connor, Hajar Hazime, Juan F Burgueño, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 219) with videos related to
Sort By:
Page
of 22
Crohn'S & Colitis 360
|
November 1, 2019
Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing
Mona Rezapour, Maria Alejandra Quintero, Nidah S Khakoo, et al.
Clinical and Translational Gastroenterology
|
June 26, 2025
Relationship of Intestinal Ultrasound With Clinical, Biochemical, and Endoscopic Disease Severity in Acute Severe Ulcerative Colitis: A Blinded, Prospective Study
Phillip Gu, David Ziring, Puja V Khanna, et al.
The American Journal of Gastroenterology
|
January 19, 2005
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab
Konstantinos A Papadakis, Omid A Shaye, Eric A Vasiliauskas, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 11, 2009
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis
Ryan Ungaro, Masayuki Fukata, David Hsu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 3, 2024
Early Life and Childhood Environmental Exposures, More Than Genetic Predisposition, Influence Age of Diagnosis in a Diverse Cohort of 2952 Patients With IBD
Nidah S Khakoo, Ashley H Beecham, Jiangnan Lyu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2010
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab
William J Sandborn, Maria T Abreu, Geert D'Haens, et al.
Inflammatory Bowel Diseases
|
September 25, 2024
Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease
Fatima S Hussain, Tomas Potlach, Xiaofei Chi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease
Uma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring
Amy Hemperly, Marla C Dubinsky, Andres Yarur, et al.
Gastroenterology
|
February 13, 2026
Quorum sensing molecules are elevated in long-standing ulcerative colitis and are linked to the development of colitis-associated cancer
Gregory O'Connor, Hajar Hazime, Juan F Burgueño, et al.
Page
of 22